CircMTO1: A circular RNA with roles in the carcinogenesis

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Circular RNAs (circRNAs) are unique RNA transcripts with a closed-loop structure, conferring high stability.
• Advances in sequencing and bioinformatics reveal circRNAs' roles in development, physiology, and cancer pathology.
• CircMTO1 was initially identified as downregulated in hepatocellular carcinoma and subsequently in various other cancers.

Purpose of the Study:

• To review the existing literature on the role of circMTO1 in tumorigenesis.
• To consolidate findings on circMTO1 expression patterns across different cancer types.
• To explore the molecular mechanisms by which circMTO1 influences cancer development.

Main Methods:

• Literature review of studies investigating circMTO1 expression and function in cancer.
• Analysis of circRNA profiling data, including microarray and sequencing techniques.
• Examination of experimental evidence linking circMTO1 to specific signaling pathways and microRNA interactions.

Main Results:

• CircMTO1 is predominantly downregulated in hepatocellular carcinoma, lung adenocarcinoma, colorectal cancer, bladder cancer, glioblastoma, prostate cancer, osteosarcoma, gastric cancer, and ovarian cancer.
• Conversely, circMTO1 expression is upregulated in cervical and gallbladder cancers.
• CircMTO1 sequesters various microRNAs (e.g., miR-17, miR-9, miR-221) and modulates key signaling pathways including Notch, Wnt/β-Catenin, TGF-β/Smad, JAK1/STAT3, and AMPK.

Conclusions:

• CircMTO1 exhibits diverse expression patterns in human cancers, suggesting context-dependent roles in tumorigenesis.
• Its ability to sponge microRNAs and regulate signaling pathways highlights its significance as a potential cancer biomarker and therapeutic target.
• Further research is warranted to fully elucidate the complex functions of circMTO1 in different oncological settings.